From the April 17, 2003 issue
PROBLEM: Accidental administration of concentrated
epinephrine has been discussed before in our newsletter. As
mentioned in one recent issue (ISMP Medication Safety Alert!
It doesn't pay to play the percentages. October 16, 2002),
many errors can be traced to confusion with expressing the
concentration as a ratio strength rather than a metric weight
per volume. But another reason for errors is confusion between
epinephrine and ephedrine. Not only do these drug names look
similar, but their use as vasopressors or vasoconstrictors
makes storage near each other likely. Both products also may
be packaged alike in 1 mL ampuls or vials. Several reports
of confusion between these drugs have come to our attention
recently.
In a labor and delivery unit, a healthy young woman became
hypotensive after epidural anesthesia was administered.
A nurse immediately called the obstetrics resident to inform
him of the patient's condition. The resident, known to be
"difficult" at times, became angry and snapped
at the nurse as he ordered ephedrine 10 mg to be given slow
IV push. When processing the order, the nurse, who was anxious
because of the physician's behavior, made a mental slip
and thought of "epinephrine." With only a few
ampuls of epinephrine 1 mg on the unit, she decided to borrow
more from the nursery. She found a 30 mL vial of epinephrine
1:1,000 (1 mg/mL), per withdrew 10 mL, and returned to administer
that amount to the patient. Almost immediately, the patient
developed tachycardia, severe hypertension, and
pulmonary edema. Fortunately, an anesthesia staff member
was present and recognized the problem immediately. The
patient was treated successfully and the baby was delivered
safely. An eerily similar scenario played out recently at
a different hospital where yet another patient was hypotensive
from epidural anesthesia. A nurse called pharmacy to report
that her automated dispensing cabinet didn't have enough
epinephrine to administer a 5 mg IV dose. A pharmacist immediately
reviewed a copy of the order in which the physician had
clearly prescribed ephedrine 5 mg IV. The reporter noted
that, had there been enough epinephrine in unit stock, a
5 mg dose might have been given.
We've also received reports where diluted ephedrine was
administered in error instead of epinephrine. In one case,
a patient received an irrigation solution during an orthopedic
procedure where ephedrine, not epinephrine, was added to
a 3 liter container. In yet another hospital, ephedrine
was used to compound an epinephrine infusion.
SAFE PRACTICE RECOMMENDATION: FDA requires manufacturers
to use "tall man" lettering on container labels
for 16 look-alike generic name pairs. But ephedrine and
epinephrine were introduced before the 1938 Food, Drug and
Cosmetic Act, and do not fall under current FDA labeling
standards. You still can change the appearance of look-alike
product names, however, by highlighting, through bold face,
color, circling, or tall man letters, the parts of the names
that are different. This form of differentiating look-alike
products should occur on computer screens, pharmacy and
nursing unit shelf labels and bins (including automated
dispensing units), pharmacy product labels, and medication
administration records. You may be able to mark drug containers
themselves to help differentiate the products and, of course,
you should never store these drugs side by side. Prescribers
should use "tall man" letters when writing orders
(e.g., EPINEPHrine, ePHEDdrine).
To the extent possible, use prefilled syringes and limit
storage of concentrated epinephrine to crash carts (except
in the ED and OR) to reduce the risk of dilution errors
or administration of the wrong product. Epinephrine 1:1,000
in 30 mL vials for systemic use represents a potential danger
and, at least in nurseries, should not be available on units.
In fact, it may not be needed on most units since high-dose
epinephrine use during CPR is no longer supported due to
the potential for harm and lack of efficacy in improving
survival in cardiac arrest (American Heart Association and
International Liaison Committee on Resuscitation. Guidelines
2000 for cardiopulmonary resuscitation and emergency cardiovascular
care. An international consensus on science. Circulation.
2000;102 (suppl 1):1-384.). Another suggestion, from a medication
safety nurse whose pharmacy supplies these products in an
automated dispensing cabinet, is to provide a screen alert
stating: "Ephedrine has been entered, is this what
you want? YES or NO." To ensure an independent doublecheck
system, it would be best to have pharmacy prepare all infusions
and bolus doses for these drugs. Visit www.gasnet.org/societies/apsf/newsletter/2002/winter/07letters.htm
for additional suggestions for preventing epinephrine-ephedrine
mix-ups from an anesthesiologist who has previously confused
these drugs (Lambert DH. Concentrated solutions cause concern.
Letter. APSF Newsletter 2002;17:65).